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Previously, our group reported a five-generation family in which a balanced t(13;17) translocation is associated
with a spectrum of skeletal abnormalities, including Robin sequence, hypoplastic scapulae, and a missing pair of
ribs. Using polymerase chain reaction (PCR) with chromosome-specific markers to analyze DNA from somatic cell
hybrids containing the derivative translocation chromosomes, we narrowed the breakpoint on each chromosome.
Subsequent sequencing of PCR products spanning the breakpoints identified the breaks precisely. The chromosome
17 breakpoint maps ∼932 kb upstream of the sex-determining region Y (SRY)–related high-mobility group box
gene (SOX9) within a noncoding transcript represented by two IMAGE cDNA clones. A growing number of reports
have implicated chromosome 17 breakpoints at a distance of up to 1 Mb from SOX9 in some cases of campomelic
dysplasia (CD). Although this multigeneration family has a disorder that shares some features with CD, their
phenotype is significantly milder than any reported cases of (nonmosaic) CD. Therefore, this case may represent
an etiologically distinct skeletal dysplasia or may be an extremely mild familial example of CD, caused by the most
proximal translocation breakpoint from SOX9 reported to date. In addition, we have refined the breakpoint in an
acampomelic CD case described elsewhere and have found that it lies ∼900 kb upstream of SOX9.
Campomelic dysplasia (CD [MIM 114290]) is a dom-
inant, frequently lethal skeletal dysplasia syndrome
whose primary features include angular bowing and
shortening of the limbs, hypoplastic scapulae, missing
ribs, a narrow thorax, tracheal abnormalities, respi-
ratory distress, club feet, dysmorphic features, and, in a
majority of affected XY individuals, partial-to-complete
sex reversal (Houston et al. 1983; Mansour et al. 1995).
Most cases of CD are caused by mutations in SOX9,
the gene encoding a member of the sex-determining re-
gion Y (SRY)–related high-mobility group box family of
transcription factors located on human chromosome
17q24.3-q25.1 (Foster et al. 1994; Wagner et al. 1994).
SRY is the gene encoding Y-linked testis-determining fac-
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tor (Sinclair et al. 1990; Koopman et al. 1991), and
mutations in SRY also cause XY sex reversal (Berta et
al. 1990; Jager et al. 1990). SOX9 is downstream of—
and may be a direct target of—SRY in the male sex-
determination cascade (Knower et al. 2003). Interest-
ingly, ectopic expression of Sox9 can induce testis de-
velopment in the absence of Sry in XX transgenic mice
(Vidal et al. 2001). During chondrogenesis, the SOX9
gene targets include the collagen-encoding genes Col2a1
and Col11a2 as well as CD-Rap (Bell et al. 1997; Le-
febvre et al. 1997; Ng et al. 1997; Bridgewater et al.
1998; Xie et al. 1999). Therefore, SOX9 expression and
targets correlate with the tissues primarily affected in
CD—namely, cartilage and testis. SOX9 mutations iden-
tified in cases of CD are inactivating, and, in two re-
ported cases, the entire SOX9 locus was deleted, which
confirms that CD is due to haploinsufficiency of SOX9
(Olney et al. 1999; Scherer et al. 1999; Pop et al. 2004).
The dose-dependent role of SOX9 in sex determination
is further supported by a case in which duplication of
the region containing SOX9 caused sex reversal in an
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Table 1
Partial Translocation Breakpoint Mapping Results for Chromosome
13 Markers in Family F, t(13;17)(q22.1;q22.3)
MARKER
FINDING IN FAMILY Fa
Translocated
MARKER
COORDINATESb
Normal der(13) der(17) Start End
13 gap 23    88356686 88356925
13 gap 27.3    88399721 88400054
13-28.7    88414493 88414730
13-30.1    88428157 88428377
13 gap 31.6    88442841 88443080
13-16    88459861 88460075
13-5550    88466013 88466273
13-11111c    88471622 88471904
13-401c    88472317 88472522
up-gap 13    88473289 88473618
down-gap 13    88474944 88475209
13-33    88476702 88476935
D13S1818d    88492889 88493108
D13S767d    88916866 88917030
D13S1190d    90149068 90149317
SHGC 16473d    90729432 90729566
D13S71d    93571723 93571797
D13S796d    106686966 106687128
a  p marker is present;  p marker is absent.
b NCBI chromosome 13 sequence, build 35.1.
c Markers flanking the breakpoint.
d Publicly available markers.
XX infant (Huang et al. 1999). Moreover, it has been
shown that dimerization of SOX9 protein is necessary
for transactivation of targets in chondrocytes but not in
testis, suggesting that different tissues should have vary-
ing sensitivities to SOX9 dose (Bernard et al. 2003; Sock
et al. 2003). However, there is no correlation between
the specific type and location of SOX9 mutation and
the sexual phenotype; at least two mutations have been
identified that cause sex reversal in one XY individual
but not in a second XY patient with an identical mu-
tation (Kwok et al. 1995; Cameron et al. 1996; Meyer
et al. 1997). This suggests that phenotypic variation is
heavily influenced by the level of expression from the
unaffected SOX9 allele and/or by stochastic factors. The
only genotype-phenotype association for which a case
can be made is the correlation between survival beyond
infancy and retention of some residual function by the
mutant SOX9 allele (Meyer et al. 1997).
Perhaps the most interesting aspect of CD is the grow-
ing number of reports in which the associated lesion is
not a SOX9 mutation but is instead a chromosome 17
rearrangement breakpoint located some distance from
SOX9 (Maraia et al. 1991; Young et al. 1992; Foster et
al. 1994; Wagner et al. 1994; Ninomiya et al. 1995,
1996; Wirth et al. 1996; Savarirayan and Bankier 1998;
Pfeifer et al. 1999; Mansour et al. 2002; Offiah et al.
2002). These breakpoints range from tens to hundreds
of kilobases upstream and downstream of SOX9 (Ve-
lagaleti et al. 2005 [in this issue]) and show no apparent
bias toward chromosomal translocation partner, and,
although affected individuals with these breakpoints
have, in general, milder phenotypes and longer survival
than those with classic CD, they still exhibit XY sex
reversal and infant mortality. On the basis of these trans-
location breakpoints, it has been speculated that regu-
latory elements for SOX9 can be located as far as 1 Mb
upstream of SOX9 (Wunderle et al. 1998; Pfeifer et al.
1999; Bagheri-Fam et al. 2001; Pop et al. 2004).
We report here the precise mapping of chromosome
17 translocation breakpoints nearly 1 Mb upstream of
SOX9 in two previously described patients with CD or
CD-like skeletal dysplasia. Patient MS was an XY male
with acampomelic CD (and a survival time of 6 years)
and a balanced t(17;22) translocation whose chro-
mosome 17 breakpoint was previously reported to be
932–966 kb upstream of SOX9 (Wagner et al. 1997;
Pfeifer et al. 1999; Pop et al. 2004). We have reanalyzed
this breakpoint and have found that it lies 900.2 kb
upstream of the SOX9 transcriptional start and within
1 kb of a breakpoint reported by Velagaleti et al. (2005).
Family F carries a balanced t(13;17) translocation and
exhibits a mild and slightly variable skeletal dysplasia,
consisting primarily of Robin-type cleft palate, a miss-
ing pair of ribs, and hypoplastic scapulae, in mem-
bers of at least five generations (Stalker and Zori 1997;
Stalker et al. 2001). We have mapped the chromosome
17 breakpoint in family F at 931.8 kb upstream of
SOX9. This case represents the translocation break-
point most proximal from SOX9 reported to date that
is associated with a skeletal dysplasia phenotype. The
breakpoint interrupts a noncoding, spliced, and poly-
adenylated transcript of unknown function that is ex-
pressed in testis.
Family F: Sequencing of the SOX9 coding region and
splice sites from family F revealed no mutations. To bet-
ter understand the skeletal dysplasia syndrome in family
F, we chose to map precisely the breakpoints in their
balanced t(13;17) translocation. As a first step, human-
mouse somatic cell hybrids were commercially made us-
ing patient leukocytes and were screened for their human
chromosome content (GMP Genetics). Using a reitera-
tive, PCR-based process of typing hybrids that contain
the derivative translocated chromosomes for chro-
mosome-specific markers, we mapped the chromosome
13 breakpoint to an interval of 413 bp and the chro-
mosome 17 breakpoint to an interval of 288 bp. Primer
sequences for nonpublic mapping markers are available
in table A1 (online only). A subset of the mapping
results is shown in tables 1 and 2. We then generated
cross-breakpoint PCR products by use of primers from
the mapping markers that fell closest to the breakpoints
(indicated in tables 1 and 2). These PCR products were
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Table 2
Partial Translocation Breakpoint Mapping Results for Chromosome 17 Markers in
Family F, t(13;17)(q22.1;q22.3), and Patient MS, t(17;22)
MARKER
FINDING IN FAMILY Fa
FINDING IN
PATIENT MS
der(22)
Translocated
MARKER
COORDINATESb
Normal der(13) der(17) Start End
D17S1350c     66600358 66600540
RH65556c     66670860 66671047
RP-20     66674098 66674497
17 gap 20530     66691461 66691719
17-2200     66694306 66694588
17-4551d     66696681 66696862
DP-29d     66697150 66697256
17-28370     66698729 66699105
17-34220     66705191 66705450
17 gap 41070     66712140 66712377
C11BP1     66718464 66718796
C11BP2     66724488 66724712
C11BP3     66726775 66727010
C11BP5     66727576 66727788
C11BP6     66728086 66728286
C11BP7e     66728349 66728522
C11BP8e     66728730 66728894
C11BP4     66728921 66729178
17 gap 600     66731367 66731624
17 gap 12     66790865 66791168
a  p marker is present;  p marker is absent.
b NCBI chromosome 17 sequence, build 35.1.
c Publicly available markers.
d Markers flanking the family F breakpoint.
e Markers flanking the patient MS breakpoint.
Figure 1 Family F translocation breakpoint sequences. Partial sequence of PCR products spanning the translocation breakpoints on the
der(13) and der(17) t(13;17) chromosomes. Normal sequences from chromosomes 13 and 17 are shown above and below the breakpoint
sequences, respectively, along with the sequence coordinate corresponding to the breakpoint. The chromosome 13 sequence is in bold, and the
chromosome 17 sequence is underlined. The boxed A nucleotide at the breakpoint junction cannot be assigned to either chromosome sequence.
The der(17) chromosome contains small deletions of 8 nt from chromosome 17 and 13 nt from chromosome 13 (dashes).
of identical size and sequence when generated from so-
matic cell hybrid DNA or patient DNA, indicating that
no extraneous rearrangements were present in the hy-
brids that would complicate our analysis (not shown).
Direct sequencing of the der(13) PCR product revealed
342 nt of chromosome 13 sequence followed immedi-
ately by 165 nt of chromosome 17 sequence (fig. 1). The
der(17) product contained small deletions of 8 nt from
chromosome 17 and 13 nt from chromosome 13 that
were adjacent to the breakpoints, perhaps as a result of
degradation of the broken ends during the translo-
cation event (fig. 1). There was no apparent homology
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Figure 2 RT-PCR and genomic organization of the BC039327 transcript. A, RT-PCR of BC039327 exons 3–4. B, Control RT-PCR for
the housekeeping transcript HPRT. Lanes are marked as follows: M p 100-bp marker; T p testis; H p heart; BM p bone marrow; C p
cerebellum; FL p fetal liver; SC p spinal cord; P p placenta; B p brain; FB p fetal brain; L p lymphocytes; NT p no template, control.
Sizes of marker bands are shown (left). C, Genomic organization of the BC039327 locus on 17q. The centromere is to the right of the figure.
Exons are represented by blackened rectangles, and exon numbers are indicated directly beneath them. The approximate positions of primers
used for RT-PCR in A are shown as arrows (not to scale). Intron spans are indicated (dashed lines), and the size of each intron is given in kb.
The position of the family F translocation breakpoint is designated by an asterisk (*). The chromosome 17 sequence coordinates (NCBI build
35.1) for the first and last (non–poly-A tail) nucleotides of the BC039327 sequence are indicated at the left and right of the locus diagram,
respectively. D, Overview of the genomic region surrounding SOX9 on 17q. Line segments equal ∼100 kb of genomic sequence each. CD
translocation breakpoints summarized by Pfeifer et al. (1999) are indicated by thin vertical arrows, located on the basis of their closest possible
position with respect to SOX9. Breakpoint positions reported in the present study and by Velagaleti et al. (2005) are indicated by thick vertical
arrows and are labeled as follows: 1p family F; 2p patient MS; 3p patient 1 in Velagaleti et al.; 4p patient 2 in Velagaleti et al. Approximate
positions of highly conserved (human, mouse, and Takifugu) sequence elements described elsewhere are indicated with asterisks (*) and are
labeled as follows: E1–E7, Bagheri-Fam et al. (2001); Q1–Q4, Qin et al. (2004); Eb1 and Eb2, Pop et al. (2004); and SOX9cre1, Velagaleti et
al. (2005). The mammalian elements R1–R10 reported by Pop et al. (2004) are not shown.
between the breakpoint sequences that might have con-
tributed to the translocation mechanism. The chromo-
some 13 break, therefore, falls at nucleotide 88471962
in the National Center for Biotechnology Informa-
tion (NCBI) chromosome 13 reference sequence (build
35.1), and the chromosome 17 break falls at nucleotide
66697091 in the NCBI chromosome 17 reference se-
quence, 931.8 kb upstream of the SOX9 transcriptional
start.
After mapping the translocation breakpoints of family
F, we examined the sequence in the vicinity of each
breakpoint for evidence of transcript(s) that might be
interrupted or otherwise affected by the translocation.
The chromosome 13 breakpoint fell within the 5′ EST
read sequence of IMAGE clone 6619359, which was
retired from the UniGene database (it was formerly clus-
ter Hs.508345) shortly after we mapped this breakpoint.
The chromosome 17 breakpoint falls within the first
intron of a transcript that has been independently iso-
lated as a cDNA at least twice: once from testis RNA
and once from an RNA pool that included testis. One
corresponding cDNA clone, IMAGE clone 5267277
(GenBank accession number BC039327), has been fully
sequenced and was used as the reference sequence for
our further investigations. A BLAST search of the
BC039327 sequence against the NCBI human chro-
mosome sequence database allowed us to determine an
intron/exon structure (shown in fig. 2C) and to visually
examine the putative intron/exon boundaries for splice-
donor and splice-acceptor sites, all of which were present
(not shown). This clone contains four exons spaced over
∼104 kb of genomic DNA, a polyadenylation signal, and
a poly-A tail. RT-PCR spanning exons 1–3 (not shown)
and exons 3–4 (fig. 2A) generated products of the ex-
pected size from testis RNA, confirming that this tran-
script is both expressed in testis and spliced. Heart,
bone marrow, cerebellum, fetal liver, spinal cord, pla-
centa, adult brain, fetal brain, lymphocytes (fig. 2A), and
adult liver (not shown) were all negative for sequence
BC039327 by RT-PCR but were positive for the house-
keeping gene hypoxanthine phosphoribosyl transferase
(HPRT) (fig. 2B). The RT-PCR reactions for BC039327
exons 3–4 generated four distinct bands, including the
expected band at ∼224 bp (arrow in fig. 2A). Sequencing
of the most prominent product (arrowhead in fig. 2A)
revealed the expected sequence of exons 3–4 and a
stretch of 185 nt that is not found in BC039327. This
185-nt sequence fell precisely at the junction of exons 3
and 4, suggesting that it corresponded to an alternatively
spliced exon. A BLAST search confirmed that this 185-
nt sequence is present on chromosome 17, between
BC039327 exons 3 and 4 and in the appropriate ori-
entation, which confirms that this sequence represents
an additional alternative exon (exon 3b) (fig. 2C) for
the transcript represented by the BC039327 sequence.
Homology searches identified exon 3b as containing an
L1-type long interspersed nuclear element repeat. The
two other bands generated by RT-PCR were not se-
quenced but are assumed to represent additional alter-
native splice forms of this transcript.
In silico translation of the BC039327 sequence (with
or without exon 3b) revealed no ORFs 169 amino acids
and no methionine initiation codon surrounded by a
Kozak consensus sequence (Kozak 1987). Therefore, this
transcript is unlikely to encode a protein and may instead
represent a functional RNA. A search for homologues
in other species revealed only tiny fragments of homol-
ogy within exon 4: 85 nt of 89% identity and 24 nt of
100% identity with mouse sequence from (syntenic)
chromosome 11, as well as similar results with rat, chim-
panzee, and gorilla sequences (data not shown). No
mouse ESTs showed any homology to the BC039327
sequence. Therefore, this transcript appears to be specific
to humans.
Patient MS: Previous analysis indicated that SOX9
sequence from patient MS was normal. Our early STS
mapping results for family F suggested that their break-
point must be very close to that reported for patient MS
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by Pfeifer et al. (1999, case 11). We used the same PCR-
based strategy and both the existing and the newly de-
signed chromosome 17–specific primer sets on somatic
cell hybrid DNA containing the der(22) chromosome to
map the breakpoint of patient MS to the 208-bp inter-
val between chromosome 17 nucleotides 66728522–
66728730 (NCBI build 35.1). This breakpoint is ∼32
kb telomeric to the family F break (table 2) and 900.2
kb 5′ of the SOX9 transcriptional start. There are no
known or predicted transcripts in the vicinity of this
breakpoint. The chromosome 22 breakpoint in this pa-
tient is located within heterochromatin and could not
be mapped.
CD usually presents as an isolated de novo condition
with a severe phenotype leading to death in infancy.
Familial cases are rare and appear to be due to paren-
tal mosaicism for a SOX9 mutation. In such cases, the
parent may be completely unaffected and yet have more
than one affected child as a result of germline mosaicism
(Shafai 1976; Mellows et al. 1980; Winter et al. 1985;
Mansour et al. 1995, 2002; Cameron et al. 1996;
McDowall et al. 1999). In other cases, the parent is
mildly affected and is diagnosed with CD only after the
birth of a severely affected child (Thurmon et al. 1973;
Lynch et al. 1993; Mansour et al. 2002; Savarirayan et
al. 2003). In at least one such case, a mutation was
confirmed in both the mother and the child (Mansour
et al. 2002). Although the mild phenotype of the parents
of patients with CD is assumed to be due to somatic
mosaicism, this has not been proven. To the best of our
knowledge, there are no reports of familial CD extending
to three or more generations. Affected individuals that
survive into adulthood show variable expression of the
classic CD features (Mansour et al. 2002; Offiah et al.
2002; Savarirayan et al. 2003). As they age, these in-
dividuals demonstrate short stature, progressive scolio-
sis, and, frequently, hearing loss. Therefore, long-term
survivors of CD have a set of phenotypic features that
is consistent and recognizable (Mansour et al. 2002).
The skeletal syndrome in family F shares several fea-
tures with CD (Stalker and Zori 1997; Stalker et al.
2005; Unger 2005). Indeed, Robin sequence, hypoplastic
scapulae, and 11 pairs of ribs—the primary features in
family F—are nearly universal in both mild and severe
forms of CD. Family F also has minor facial dysmorph-
ism consisting of flat face, broad nasal bridge, micro-
gnathia, and hypertelorism that is consistent with CD.
However, many of the other features of CD are not pre-
sent in this family: stature and lifespan are normal; there
is no bowing of the long bones and no clubbing of the
feet; pelvic bones, spine, and epiphyses are normal; and
there is no evidence of sex reversal. The respiratory dif-
ficulty reported for one affected child (Stalker and Zori
1997) was believed by the family to be caused by a large
cleft palate, although medical records were not avail-
able, so this finding is purely anecdotal and cannot be
confirmed. Most notably, the scoliosis and hearing loss
that are nearly ubiquitous in long-term survivors of CD,
as reported by Mansour et al. (2002), are not seen in
family F. Therefore, although family F displays a skeletal
dysplasia reminiscent of CD, it remains unclear whether
this syndrome is unique or is, in fact, an extremely mild
form of CD (Stalker et al. 2005; Unger 2005).
Although CD is usually caused by mutation of SOX9,
14 cases to date have been reported in which the only
identifiable lesion is a chromosomal rearrangement in-
volving the long arm of chromosome 17. SOX9 is found
at 17q24.3-25.1, and the chromosomal breakpoints as-
sociated with CD occur as far as 1 Mb upstream (or 11
Mb downstream, as reported by Velagaleti et al. [2005])
of SOX9. The data suggest that SOX9 possesses regu-
latory elements that are extraordinarily distant, extend-
ing 1 Mb upstream and 11 Mb downstream of the SOX9
coding region. This inference is supported by data from
the Odd Sex mouse, in which insertion of a transgene
driven by the dopachrome tautomerase (Dct) promoter
980 kb upstream of murine Sox9 leads to inappropriate
expression of Sox9 in XX gonads and to XX sex reversal
(Bishop et al. 2000; Qin et al. 2004), demonstrating that
sequence ∼1 Mb upstream of Sox9 is able to affect Sox9
expression. Supporting evidence for long-distance reg-
ulation of SOX9 is also provided by a CD case with a
deletion extending from 380 kb to 1.869 Mb 5′ of
SOX9 (Pop et al. 2004). Studies of human SOX9 5′
sequence in mouse have shown that 350 kb of upstream
sequence was sufficient to drive normal-level expression
of a SOX9:lacZ reporter gene in cartilage but not in
testis, whereas 88 kb of upstream sequence gave little
to no lacZ expression except in neuroectoderm, in which
expression was delayed (Wunderle et al. 1998). Com-
parison of sequence between human, mouse, and Taki-
fugu revealed five conserved sequence elements in the
290 kb 5′ of SOX9, many of which are separated from
SOX9 by CD translocations (Bagheri-Fam et al. 2001).
Qin et al. (2004) reported four sequence elements, 390–
800 kb upstream of SOX9, that are conserved between
human, mouse, and chicken. Pop et al. (2004) examined
1.5 Mb of sequence upstream of SOX9 and identified
two widely conserved sequence elements 395 kb and 611
kb upstream of human SOX9, as well as 10 sequence
elements farther upstream that are conserved only be-
tween human and mouse. It has been suggested that one
or more of these elements may be responsible for testis-
specific regulation of SOX9, because all 12 are deleted
in a CD case with a 1.5-Mb 17q interstitial deletion and
sex reversal, whereas 350 kb of SOX9 5′ sequence is
insufficient for expression of a SOX9 reporter in testis
(Wunderle et al. 1998; Pop et al. 2004). However, 7 of
the 10 more-centromeric elements are separated from
SOX9 in both of the translocation cases addressed in
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the present study, of which one exhibits acampomelic
CD without sex reversal and the other displays a mild,
familial skeletal dysplasia with no sex reversal. There-
fore, the role of the identified conserved sequence ele-
ments in regulation of SOX9 remains to be determined.
However, Velagaleti et al. (2005) provide evidence that
a conserved sequence element ∼1.1 Mb upstream of
SOX9 is in close physical proximity to the SOX9 locus
in interphase chromosomes, supporting the possibility
of SOX9 regulation by distant regulatory elements. Such
long-range elements have been demonstrated for the
genes POU3F4 (de Kok et al. 1996), Sonic hedgehog
(Lettice et al. 2003), MAF (Jamieson et al. 2002), and
DACH (Nobrega et al. 2003). A summary of the re-
ported CD translocation breakpoints and widely con-
served potential SOX9 regulatory elements is provided
in figure 2D. It is interesting to note that, although con-
served sequence elements have been identified through-
out the 1 Mb of sequence upstream of SOX9, there is
a marked absence of reported CD translocation break-
points in the region 300–900 kb upstream.
Although there are no protein-coding genes within the
1 Mb of sequence 5′ of SOX9, the family F breakpoint
interrupts a noncoding transcript that extends over∼104
kb of genomic sequence and is spliced and polyadeny-
lated. Because of the CD-like phenotype in this family,
it is possible that the interrupted transcript is involved
in regulation of SOX9 as a functional RNA. Since CD
is due to loss of SOX9 function, the potential role of
this transcript is most likely that of a positive regulator.
Of 11 tissues tested by RT-PCR, the BC039327 sequence
was detected only in testis. Although this result is con-
sistent with a potential role in SOX9 regulation, there
is no testis phenotype in family F. It may be that a single
copy of BC039327 is sufficient for normal SOX9 reg-
ulation in testis but not in chondrocytes, thereby gen-
erating the skeletal-specific phenotype. Alternatively, this
transcript may play a role in chondrogenesis that is un-
related to SOX9. It should be noted that several other
noncoding transcripts of unknown function have been
identified in the region around SOX9, some of which
are also expressed in testis (Ninomiya et al. 1996; Pfeifer
et al. 1999; Bagheri-Fam et al. 2001). Alternatively, the
disruption of the BC039327 transcript may be coinci-
dental, and the syndrome in this family may be caused
by misregulation of SOX9 due to separation from one
or more distant regulatory elements. The fact that this
translocation breakpoint is the farthest one (upstream)
from SOX9 reported to date suggests that it leaves the
majority of the SOX9 regulatory region intact, perhaps
accounting for the mild phenotype in this family. The
CD translocations in patient MS (in the present report)
and patient 1 (in Velagaleti et al. [2005]) are 32 kb
telomeric to the family F breakpoint and, remarkably,
are 1 kb apart at most. These are the only CD break-
points reported to fall within 600 kb of the family F
breakpoint. The difference in phenotypic severity and
diagnosis between family F and these patients suggests
that the intervening 32 kb of sequence may be important
for SOX9 regulation, although no potential regulatory
elements have been reported in this interval. Wirth et al.
(1996) were able to demonstrate expression from both
SOX9 alleles in a patient with CD and a t(13;17) trans-
location; however, this experiment used lymphoblast
RNA, which may not reflect expression in the devel-
opmentally relevant tissues—fetal testis and chondro-
cytes. Indeed, it is essentially impossible to obtain patient
samples that would allow meaningful analysis of SOX9
expression and regulation. Therefore, the elucidation of
how the DNA sequence surrounding SOX9 contributes
to its regulation must, for the present, continue to rely
on circumstantial evidence of CD translocation break-
points and comparative sequence analyses. Such studies
will not only add to our understanding of how one of
the most important factors in development, SOX9, is
regulated but will also shed light on the roles of gene-
poor “desert” regions in the genome.
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